Why does ANSES maintain the creatine limit at 3 g? The conclusions of the agency for athletes

Why does ANSES maintain the creatine limit at 3 g? The conclusions of the agency for athletes
In an opinion published on November 9, 2026, ANSES does not recommend increasing the French limit for creatine in food supplements. Not because 5 g would be officially “toxic”, but because the safety of use is not sufficiently demonstrated.

In a gym, creatine sometimes flows as naturally as training advice: a spoon in a shaker, a promise of power, and the impression of a well-known product. However, on the regulatory side, ANSES has just adopted a cautious position. In a notice dated October 20 and published on November 9, 2026, the health agency does not recommend increasing the maximum amount of creatine authorized in food supplements to 5 g per day.

The key point lies in an important nuance: ANSES does not say that 5 g per day is proven to be toxic for everyone. She believes that the data transmitted is not enough to demonstrate job security strong enough to modify the current French rule.

What did the file under review really ask for?

In France, food supplement regulations currently limit creatine to 3,000 mg in the recommended daily portion. The request examined by ANSES aimed to change this ceiling for certain products intended in particular for athletes.

In the file, a petitioner claimed 5 g per day of creatine monohydrate in the maintenance phase, i.e. 4.4 g of creatineand 20 g per day of creatine monohydrate in the loading phase, or 17.6 g of creatine. Another product, presented in the form of gummies, provided 4 g of creatine monohydrate per recommended daily portion, or 3.5 g of creatine; for this second product, ANSES had labeling and transmitted articles, but not a complete scientific file.

In other words, the opinion does not relate to an individualized medical prescription, but to a request to modify the conditions of use in food supplements. To better understand in which cases creatine can be useful, we must therefore distinguish between sports use, the regulatory framework and the real level of available evidence.

Why is the evidence not enough to change the limit?

Creatine is one of the most studied supplements in sports nutrition. This does not mean, however, that all doses, all consumer profiles and all durations of use are established with the same degree of certainty.

In its opinion, ANSES analyzes in particular the data submitted by the petitioners. She notes that a systematic review with meta-analysis published in 2019 did not demonstrate an association with impaired renal function. But the agency also highlights important limitations: sometimes low numbers, mostly short durations, populations studied which do not allow generalizations to be made to all consumers or regular long-term intake.

Other reviews, more narrative, report good tolerance in certain situations. ANSES does not say that these reviews conclude that there is a dangerbut that they are too fragmentary or incomplete to justify the regulatory modification requested.

Its conclusion therefore remains cautious: the data transmitted do not demonstrate safety of use at the claimed daily contents, i.e. 4 g or 5 g in the maintenance period and 20 g in the loading period. This position may seem frustrating for some practitioners, accustomed to seeing higher protocols circulating. But for a health authority, the absence of a clear signal of danger is not always enough to authorize wider exposure of the population.

What this caution reminds athletes of

ANSES also highlights a point that is often underestimated: supplements intended for athletes may be subject to reports of adverse effects via nutrivigilance. These reports do not automatically prove that creatine is responsible, but they warrant increased vigilance, especially when several ingredients are combined.

Another area of ​​concern: the risk of adulteration of food supplements intended for athletes, in particular those with an ergogenic aim (i.e. the possibility that a product is falsified by the addition, substitution or dilution with a substance of lesser value, undeclared or harmful). Some products may contain prohibited substances, such as anabolic steroids, clenbuterol or ephedrine. The risk is not only health-related: it can also result in a positive doping test. Internet purchases, poorly controlled circuits or overly spectacular promises therefore deserve particular attention. Before buying, it is better to find out about the criteria for choosing food supplements for sports.

The agency strongly advises against supplements aimed at muscle development or the reduction of fat mass for several audiences: people with cardiovascular risk factors, heart disease, renal or hepatic impairment, neuropsychiatric disorders, but also children, adolescents, pregnant or breastfeeding women.

For other consumers, the right reflex remains to
talk about your goals and what you are taking with a doctor, pharmacist or healthcare professionalespecially in the event of treatment, known illness or intensive sports practice. Supplements are not trivial products and the risks associated with food supplements are often minimized.

The ANSES opinion therefore does not signal the end of creatine. Above all, he reminds us that before expanding a maximum authorized dose, the evidence must correspond to real uses: repeated doses, products sometimes combined, and consumers who are not all young athletes in perfect health.